| Name | Title | Contact Details |
|---|
NuWave is a Upland, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
EIS Analytics is a Vancouver, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Established as a non-profit organization in 1995, the Upper Chesapeake Health Foundation is dedicated to supporting UCH and its vision to create the healthiest community in Maryland. The funds raised are managed in accordance with donor wishes,
Prime Medica is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.